CareDx (CDNA) director exercises 26,500 options, now holds 183,961 shares

Rhea-AI Filing Summary

CareDx, Inc. director Michael Goldberg exercised stock options to acquire additional common shares. On March 31, 2026, he exercised options covering 26,500 shares of CareDx common stock at exercise prices of $5.02, $4.95, and $1.22 per share.

Following these option exercises, Goldberg directly owned 183,961 shares of CareDx common stock. The exercised options were originally subject to vesting schedules beginning in 2016 and 2017, with monthly vesting thereafter as described in the filing footnotes. No sales or gifts were reported in this filing.

Insider Trade Summary

26,500 shares exercised/converted

Mixed 6 txns

Insider Goldberg Michael

Role Director

Type	Security	Shares	Price	Value
Exercise	Stock Option (right to buy)	5,255	$0.00	--
Exercise	Stock Option (right to buy)	9,745	$0.00	--
Exercise	Stock Option	11,500	$0.00	--
Exercise	Common Stock	5,255	$5.02	$26K
Exercise	Common Stock	9,745	$4.95	$48K
Exercise	Common Stock	11,500	$1.22	$14K

Holdings After Transaction: Stock Option (right to buy) — 0 shares (Direct); Stock Option — 0 shares (Direct); Common Stock — 162,716 shares (Direct)

Footnotes (1)

1. 1/12th of the shares subject to the option shall vest on July 16, 2016 and 1/12th of the shares subject to the option shall vest monthly thereafter. 1/12th of the shares subject to the option shall vest on August 1, 2016 and the shares subject to the option shall vest monthly thereafter through the earlier of the next annual shareholder meeting or July 1, 2017. 1/12th of the shares subject to the option shall vest on August 13, 2017 and the shares subject to the option shall vest monthly thereafter through July 13, 2018.

Key Figures

Options exercised: 26,500 shares Exercise price: $5.02 per share Exercise price: $4.95 per share +5 more

8 metrics

Options exercised 26,500 shares Total derivative shares exercised on March 31, 2026

Exercise price $5.02 per share Stock Option (right to buy) into common stock

Exercise price $4.95 per share Stock Option (right to buy) into common stock

Exercise price $1.22 per share Stock Option into common stock

Shares acquired at $5.02 5,255 shares Common stock from option exercise on March 31, 2026

Shares acquired at $4.95 9,745 shares Common stock from option exercise on March 31, 2026

Shares acquired at $1.22 11,500 shares Common stock from option exercise on March 31, 2026

Shares held after transactions 183,961 shares Total direct CareDx common stock owned by Michael Goldberg

Key Terms

Stock Option (right to buy), derivative security, Common Stock, vesting, +1 more

5 terms

Stock Option (right to buy) financial

"security_title: "Stock Option (right to buy)""

derivative security financial

"transaction_code_description: "Exercise or conversion of derivative security""

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

Common Stock financial

"underlying_security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

vesting financial

"shares subject to the option shall vest monthly thereafter"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

exercise price financial

"conversion_or_exercise_price: "5.0200""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Goldberg Michael

(Last) (First) (Middle)

C/O CAREDX, INC.

8000 MARINA BOULEVARD, 4TH FLOOR

(Street)

BRISBANE CALIFORNIA 94005

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CareDx, Inc. [ CDNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/31/2026		M		5,255	A	$5.02	162,716	D
Common Stock	03/31/2026		M		9,745	A	$4.95	172,461	D
Common Stock	03/31/2026		M		11,500	A	$1.22	183,961	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$5.02	03/31/2026		M			5,255	(1)	06/16/2026	Common Stock	5,255	$0	0	D
Stock Option (right to buy)	$4.95	03/31/2026		M			9,745	(2)	07/15/2026	Common Stock	9,745	$0	0	D
Stock Option	$1.22	03/31/2026		M			11,500	(3)	07/13/2027	Common Stock	11,500	$0	0	D

Explanation of Responses:

1. 1/12th of the shares subject to the option shall vest on July 16, 2016 and 1/12th of the shares subject to the option shall vest monthly thereafter.

2. 1/12th of the shares subject to the option shall vest on August 1, 2016 and the shares subject to the option shall vest monthly thereafter through the earlier of the next annual shareholder meeting or July 1, 2017.

3. 1/12th of the shares subject to the option shall vest on August 13, 2017 and the shares subject to the option shall vest monthly thereafter through July 13, 2018.

	/s/ Jeffrey Adam Novack, Attorney-in-Fact	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did CareDx (CDNA) director Michael Goldberg report?

Michael Goldberg reported exercising stock options to acquire 26,500 shares of CareDx common stock. The options converted into common shares at exercise prices of $5.02, $4.95, and $1.22 per share, with all transactions dated March 31, 2026.

How many CareDx (CDNA) shares does Michael Goldberg hold after this Form 4?

After the reported transactions, Michael Goldberg directly holds 183,961 shares of CareDx common stock. This total reflects the addition of 26,500 shares acquired through stock option exercises on March 31, 2026, as shown in the Form 4 data.

What stock option exercise prices were disclosed in the CareDx (CDNA) Form 4?

The Form 4 shows stock options exercised at three exercise prices: $5.02, $4.95, and $1.22 per share. Each option exercise converted into an equal number of CareDx common shares, totaling 26,500 shares across the three option grants.

Did the CareDx (CDNA) Form 4 show any stock sales by Michael Goldberg?

The Form 4 reports only option exercises coded as “M” for derivative exercise or conversion, with no transactions marked as sales. All six transactions are classified as acquisitions, and the net buy-sell direction in the summary is listed as neutral.

What vesting terms are disclosed for Michael Goldberg’s CareDx (CDNA) options?

Footnotes state that portions of the option grants began vesting in 2016 and 2017. One grant vested 1/12th on July 16, 2016, another on August 1, 2016, and another on August 13, 2017, with remaining shares vesting monthly thereafter under each schedule.